Abstract
Myelodysplastic syndromes (MDSs) are a heterogeneous group of hematological disorders characterized by ineffective hematopoiesis, enhanced bone marrow apoptosis and frequent progression to acute myeloid leukemia. Several recent studies suggested that, besides the abnormal development of stem cells, microenvironmental alterations are also present in the MDS bone marrow. In this study, we have examined the relative frequencies of stem and progenitor cell subsets of MDS and normal hematopoietic cells growing on stromal cell layers established from MDS patients and from normal donors. When hematopoietic cells from MDS patients were co-cultured with normal stromal cells, the frequency of either early or late cobblestone area-forming cells (CAFC) was significantly lower compared to the corresponding normal control values in 4 out of 8 patients. In the opposite situation, when normal hematopoietic cells were incubated on MDS stromal cells, the CAFC frequencies were decreased in 5 out of 6 patients, compared to normal stromal layer-containing control cultures. Moreover, a soluble Notch ligand (Jagged-1 protein) was an inhibitor of day-35-42 CAFC when normal hematopoietic cells were cultured with normal or MDS stromal cells, but was unable to inhibit MDS stem and early progenitor cell growth (day-35-42 CAFC) on pre-established stromal layers. These findings suggest that in early hematopoietic cells isolated from MDS patients the Notch signal transduction pathway is disrupted. Furthermore, there was a marked reduction in the plasticity of mesenchymal stem cells of MDS patients compared with those of normal marrow donors, in neurogenic and adipogenic differentiation ability and hematopoiesis supporting capacityin vitro. These results are consistent with the hypothesis that when alterations are present in the myelodysplastic stroma environment along with intrinsic changes in a hematopoietic stem/progenitor cell clone, both factors might equally contribute to the abnormal hematopoiesis in MDS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AML:
-
acute myeloid leukemia
- BFU-E:
-
burst-forming units erythroid
- BM:
-
bone marrow
- CAFC:
-
cobblestone area-forming cells
- CFU-GEMM:
-
colony-forming units granulocyte-erythrocyte-macrophage-megakaryocyte (GEMM)
- CFU-GM:
-
colony-forming units granulocyte-macrophage
- MDS:
-
myelodysplastic syndromes
- MSC:
-
mesenchymal stem cells
- RA:
-
refractory anemia
- RAEB:
-
RA with excess blasts
- RARS:
-
RA with ringed sideroblasts
References
Aizawa S, Nakano M, Iwase O, et al: Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res 23: 239–246, 1999
Alvi S, Shaher A, Shetty V, et al: Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leuk Res 25: 941–954, 2001
Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770–776, 1999
Baldrón V, Ruiz-Hidalgo MJ, Nueda ML, et al: Dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res 303: 343–359, 2005
Borojevic R, Roela RA, Rodarte RS, et al: Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression. Leuk Res 28: 831–844, 2004
Breems DA, Blokland EAW, Neben S, Ploemacher RE: Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8: 1095–1104, 1994
Coutinho LH, Geary CG, Chang J, et al: Functional studies of bone marrow haematopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br J Haematol 75: 16–25, 1990
Flores-Figueroa E, Arana-Trejo RM, Gutiérrez-Espindola G, et al: Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 29: 215–224, 2005
Flores-Figueroa E, Gutiérrez-Espindola G, Montesinos JJ, et al: In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 26: 677–686, 2002
Hofmann W-K, de Vos S, Komor M, et al: Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100: 3553–3560, 2002
Jones P, May G, Healy L, et al: Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 92: 1505–1511, 1998
Karanu FN, Murdoch B, Gallacher L, et al: The Notch ligand Jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 192: 1365–1372, 2000
Lai EC: Notch signaling: control of cell communication and cell fate. Development 131: 965–973, 2004
Länger F, Stickel J, Tessema M, et al: Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines. Leuk Res 28: 1081–1083, 2004
Liesveld JL, Jordan CT, Philips GL: The hematopoietic stem cell in myelodysplasia. Stem Cells 22: 590–599, 2004
Miyazato A, Ueno S, Ohmine K, et al: Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 98: 422–427, 2001
Murata-Ohsawa M, Tohda S, Nara N: Cellular analysis of growth suppression induced by the Notch ligands, Delta-1 and Jagged-1 in two myeloid leukemia cell lines. Int J Mol Med 14: 223–226, 2004
Ohishi K, Katayama N, Shiku H, et al: Notch signalling in hematopoiesis. Semin Cell Dev Biol 14: 143–150, 2003
Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147, 1999
Radtke F, Wilson A, Mancini SJC, MacDonald HR: Notch regulation of lymphocyte development and function. Nat Immunol 5: 247–253, 2004
Shetty V, Hussaini S, Alvi S, et al: Excessive apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical confronting cisternae in bone marrow biopsies of myelodysplastic syndrome patients. Br J Haematol 116: 817–825, 2002
Steensma DP, Tefferi A: The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 27: 95–120, 2003
Tauro S, Hepburn MD, Bowen DT, Pippard MJ: Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica 86: 1038–1045, 2001
Tauro S, Hepburn MD, Peddie CM, et al: Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia 16: 785–790, 2002
Tennant GB, Walsh V, Tauran LN, et al: Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia. Br J Haematol 111: 853–862, 2000
Tohda A, Nara N: Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 42: 467–472, 2001
Tohda S, Sakano S, Ohsawa M, et al: A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates in response to Notch ligand, Delta-1 protein. Br J Haematol 117: 467–472, 2002
Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100: 2292–2302, 2002
Varnum-Finney B, Xu L, Brashem-Stein C, et al: Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 6: 1278–1281, 2000
Vas V, Szilágyi L, Pálóczi K, Uher F: Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay. J Leuk Biol 75: 714–720, 2004
Weng AP, Aster JC: Multiple niches for Notch in cancer: context is everything. Curr Opin Gen Dev 14: 48–54, 2004
Wetzler M, Kurzrock R, Estrov Z, et al: Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk Res 19: 23–34, 1995
Woodbury D, Schwarz EJ, Prockop DJ, Black IB: Adult human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364–370, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varga, G., Kiss, J., Várkonyi, J. et al. Inappropriate notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Pathol. Oncol. Res. 13, 311–319 (2007). https://doi.org/10.1007/BF02940310
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02940310